Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

Share Price is delayed by 15 minutes
Get Live Data
285.00    0.00 (0.00%)
Bid:
280.00
Ask:
290.00
Spread: 10.00 (3.571%)
Market Cap: £49.67m
TRD Live PriceLast checked at - London Stock Exchange

Intraday Triad Share Chart

Director/PDMR Shareholding

11 Jul 2018 16:00

RNS Number : 3599U
Triad Group Plc
11 July 2018
 

Legal Entity Identifier (LEI) No. 213800MDNBFVEQEN1G84

 

 

Triad Group plc

("Triad" or "the Company")

 

Director/PDMR Shareholding

 

Triad Group Plc, the UK-based IT consulting, solutions and resourcing company, was notified on 6 July 2018 that Nick Burrows, Finance Director, has exercised 5,000 options over Ordinary shares of 1p each ("Ordinary Shares"), granted pursuant to the Company's 2008 Share Option Scheme, at an exercise price of 14 pence per Ordinary share. In addition, other employees exercised 25,000 options over Ordinary Shares at an exercise price of 14 pence per Ordinary share and 20,000 options over Ordinary shares at an exercise price of 11p per Ordinary share.

 

These 50,000 Ordinary Shares were admitted to trading on 10 July 2018 pursuant to an existing block listing granted to the Company by London Stock Exchange plc and will rank pari passu with existing Ordinary Shares.

 

Following the issue of these Ordinary Shares, the total number of voting rights in Triad is 15,765,979, which number should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of Triad under the FCA's Disclosure and Transparency rules.

 

 

For further information, please contact:

 

Triad Group Plc

 

Nick Burrows, Company Secretary

 

Tel: 01908 278450

 

Arden Partners plc

 

Chris Hardie

Benjamin Cryer

 

Tel: 020 7614 5920

 

 

 

 

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nick Burrows

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Triad Group Plc

b)

 

LEI

 

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN : GB0009035741

 

b)

 

Nature of the transaction

 

 

Exercise of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£0.14

5,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A (Single transaction)

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

6 July 2018

f)

 

Place of the transaction

 

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUAVSRWWABAAR
Date   Source Headline
2nd Mar 20261:00 pmRNSDirectorate change
5th Feb 202611:00 amRNSDirector/PDMR Shareholding
27th Jan 20262:00 pmRNSDirector Dealing
20th Jan 20262:30 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:00 pmRNSTotal Voting Rights
23rd Dec 202512:00 pmRNSTotal Voting Rights
25th Nov 20257:00 amRNSHalf-year Financial Report
26th Sep 20253:00 pmRNSDirector dealings
15th Sep 202512:00 pmRNSBlock listing Review
20th Aug 20252:30 pmRNSNotification of Major Holdings
18th Aug 20252:00 pmRNSDirector/PDMR Shareholding
30th Jul 202510:30 amRNSResult of AGM
7th Jul 20253:45 pmRNSNotice of AGM and Dividend declaration
2nd Jul 202510:30 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSFinal Results
1st Apr 202511:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
19th Mar 20254:00 pmRNSDirector/PDMR Shareholding
14th Mar 20252:00 pmRNSBlock listing Review
7th Nov 20247:00 amRNSHalf-year Report
5th Nov 20244:30 pmRNSCommittee changes
30th Sep 20242:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20242:00 pmRNSDirector/PDMR Shareholding
20th Sep 20242:00 pmRNSDirectorate Change
16th Sep 20242:30 pmRNSBlock listing Interim Review
5th Sep 202412:00 pmRNSHolding(s) in Company
23rd Aug 20242:00 pmRNSResult of AGM
22nd Aug 202411:00 amRNSTrading Statement
9th Aug 20243:00 pmRNSHolding(s) in Company
31st Jul 20243:00 pmRNSNotice of AGM
31st Jul 20242:00 pmRNSHolding(s) in Company
31st Jul 20242:00 pmRNSDirector/PDMR Shareholding
29th Jul 20242:00 pmRNSDirector/PDMR Shareholding
25th Jul 20242:00 pmRNSTotal Voting Rights
25th Jul 20242:00 pmRNSDividend and AGM declaration
15th Jul 202410:00 amRNSHolding(s) in Company
11th Jul 202411:45 amRNSDirector/PDMR Shareholding
10th Jul 20241:57 pmRNSHolding(s) in Company
10th Jul 20241:55 pmRNSHolding(s) in Company
10th Jul 20241:50 pmRNSHolding(s) in Company
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:30 pmRNSHolding(s) in Company
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
1st Jul 20243:00 pmRNSDirectorate Change
26th Jun 20247:00 amRNSAnnual Financial Report
14th Jun 202412:00 pmRNSHolding(s) in Company
3rd Jun 202410:00 amRNSTotal Voting Rights
1st May 20245:00 pmRNSTotal Voting Rights
1st May 20245:00 pmRNSHolding(s) in Company
14th Mar 20243:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.